AMONGAgreement and Plan of Merger • June 2nd, 1999 • Ewok Acquisition Corp • In vitro & in vivo diagnostic substances • Massachusetts
EMPLOYMENT AGREEMENT THIS AGREEMENT is entered into this 27th day of May, 1999, by and between EWOK ACQUISITION CORP., a Massachusetts corporation (hereinafter "EWOK"), and CHRISTINE A. BURNS (hereinafter "BURNS"). WHEREAS, EWOK is proposing to...Employment Agreement • June 2nd, 1999 • Ewok Acquisition Corp • In vitro & in vivo diagnostic substances • Massachusetts
STOCKHOLDER AGREEMENT STOCKHOLDER AGREEMENT, dated as of May 27, 1999 (this "Agreement") among PERBIO SCIENCE AB, a Swedish corporation, ("Parent"), EWOK ACQUISITION CORP., a Massachusetts corporation and a wholly owned subsidiary of Parent ("Sub")...Stockholder Agreement • June 2nd, 1999 • Ewok Acquisition Corp • In vitro & in vivo diagnostic substances • Massachusetts
Perstorp Group - Perstorp AB Makes Offer Page 1 of 2 PERSTORP AB MAKES OFFER FOR AMERICAN BIOTECHNOLOGY COMPANY Perstorp AB subsidiary PerBio Science AB today executed a definitive agreement that provides for cash tender offer for all of the...Ewok Acquisition Corp • June 2nd, 1999 • In vitro & in vivo diagnostic substances
Perstorp AB subsidiary PerBio Science AB today executed a definitive agreement that provides for cash tender offer for all of the outstanding shares of Endogen Inc., an American biotechnology company. Endogen, which is listed on Nasdaq SmallCap in New York and the Boston Stock Exchange, has annual sales of approximately USD 10 million (approx. SEK 85 million).
OFFER TO PURCHASE ALL OUTSTANDING SHARES OF COMMON STOCK OF ENDOGEN, INC. AT $3.75 NET PER SHARE IN CASH BY EWOK ACQUISITION CORP. A WHOLLY OWNED SUBSIDIARY OF PERBIO SCIENCE ABMerger Agreement • June 2nd, 1999 • Ewok Acquisition Corp • In vitro & in vivo diagnostic substances
